RATIONALE: We have previously demonstrated that experimental pneumococcal carriage enhances immunity and protects healthy adults against carriage reacquisition after rechallenge with a homologous strain. OBJECTIVES: To investigate the role of naturally acquired pneumococcal protein and polysaccharide (PS)-specific immunity in protection against carriage acquisition using a heterologous challenge model. METHODS: We identified healthy volunteers that were naturally colonized with pneumococcus and, after clearance of their natural carriage episode, challenged them with a heterologous 6B strain. In another cohort of volunteers we assessed 6BPS-specific, PspA-specific, and PspC-specific IgG and IgA plasma and memory B-cell populations before and 7, 14, and 35 days after experimental pneumococcal inoculation. MEASUREMENTS AND MAIN RESULTS: Heterologous challenge with 6B resulted in 50% carriage among volunteers with previous natural pneumococcal carriage. Protection from carriage was associated with a high number of circulating 6BPS IgG-secreting memory B cells at baseline. There were no associations between protection from carriage and baseline levels of 6BPS IgG in serum or nasal wash, PspA-specific, or PspC-specific memory B cells or plasma cells. In volunteers who did not develop carriage, the number of circulating 6BPS memory B cells decreased and the number of 6BPS plasma cells increased postinoculation. CONCLUSIONS: Our data indicate that naturally acquired PS-specific memory B cells, but not levels of circulating IgG at time of pneumococcal exposure, are associated with protection against carriage acquisition.
RATIONALE: We have previously demonstrated that experimental pneumococcal carriage enhances immunity and protects healthy adults against carriage reacquisition after rechallenge with a homologous strain. OBJECTIVES: To investigate the role of naturally acquired pneumococcal protein and polysaccharide (PS)-specific immunity in protection against carriage acquisition using a heterologous challenge model. METHODS: We identified healthy volunteers that were naturally colonized with pneumococcus and, after clearance of their natural carriage episode, challenged them with a heterologous 6B strain. In another cohort of volunteers we assessed 6BPS-specific, PspA-specific, and PspC-specific IgG and IgA plasma and memory B-cell populations before and 7, 14, and 35 days after experimental pneumococcal inoculation. MEASUREMENTS AND MAIN RESULTS: Heterologous challenge with 6B resulted in 50% carriage among volunteers with previous natural pneumococcal carriage. Protection from carriage was associated with a high number of circulating 6BPS IgG-secreting memory B cells at baseline. There were no associations between protection from carriage and baseline levels of 6BPS IgG in serum or nasal wash, PspA-specific, or PspC-specific memory B cells or plasma cells. In volunteers who did not develop carriage, the number of circulating 6BPS memory B cells decreased and the number of 6BPS plasma cells increased postinoculation. CONCLUSIONS: Our data indicate that naturally acquired PS-specific memory B cells, but not levels of circulating IgG at time of pneumococcal exposure, are associated with protection against carriage acquisition.
Entities:
Keywords:
antibodies; memory B cells; plasma B cells; pneumococcal carriage; pneumococcal polysaccharide
Authors: L Salleras; A Domínguez; P Ciruela; C Izquierdo; E Navas; N Torner; E Borras Journal: Clin Microbiol Infect Date: 2009-08-18 Impact factor: 8.067
Authors: Adam K A Wright; Daniela M Ferreira; Jenna F Gritzfeld; Angela D Wright; Kathryn Armitage; Kondwani C Jambo; Emily Bate; Sherouk El Batrawy; Andrea Collins; Stephen B Gordon Journal: PLoS Pathog Date: 2012-04-05 Impact factor: 6.823
Authors: Ying-Jie Lu; Jane Gross; Debby Bogaert; Adam Finn; Linda Bagrade; Qibo Zhang; Jay K Kolls; Amit Srivastava; Anna Lundgren; Sophie Forte; Claudette M Thompson; Kathleen F Harney; Porter W Anderson; Marc Lipsitch; Richard Malley Journal: PLoS Pathog Date: 2008-09-19 Impact factor: 6.823
Authors: Rebecca A Gladstone; Johanna M Jefferies; Anna S Tocheva; Kate R Beard; David Garley; Wei Wei Chong; Stephen D Bentley; Saul N Faust; Stuart C Clarke Journal: Vaccine Date: 2015-03-14 Impact factor: 3.641
Authors: E N Janoff; J B Rubins; C Fasching; D Charboneau; J T Rahkola; A G Plaut; J N Weiser Journal: Mucosal Immunol Date: 2013-07-03 Impact factor: 7.313
Authors: Adam K A Wright; Mathieu Bangert; Jenna F Gritzfeld; Daniela M Ferreira; Kondwani C Jambo; Angela D Wright; Andrea M Collins; Stephen B Gordon Journal: PLoS Pathog Date: 2013-03-28 Impact factor: 6.823
Authors: Elena Mitsi; Beatriz Carniel; Jesús Reiné; Jamie Rylance; Seher Zaidi; Alessandra Soares-Schanoski; Victoria Connor; Andrea M Collins; Andreas Schlitzer; Elissavet Nikolaou; Carla Solórzano; Sherin Pojar; Helen Hill; Angela D Hyder-Wright; Kondwani C Jambo; Marco R Oggioni; Megan De Ste Croix; Stephen B Gordon; Simon P Jochems; Daniela M Ferreira Journal: Am J Respir Crit Care Med Date: 2020-02-01 Impact factor: 21.405
Authors: Caroline M Weight; Cristina Venturini; Sherin Pojar; Simon P Jochems; Jesús Reiné; Elissavet Nikolaou; Carla Solórzano; Mahdad Noursadeghi; Jeremy S Brown; Daniela M Ferreira; Robert S Heyderman Journal: Nat Commun Date: 2019-07-16 Impact factor: 14.919
Authors: Wouter A A de Steenhuijsen Piters; Simon P Jochems; Elena Mitsi; Jamie Rylance; Sherin Pojar; Elissavet Nikolaou; Esther L German; Mark Holloway; Beatriz F Carniel; Mei Ling J N Chu; Kayleigh Arp; Elisabeth A M Sanders; Daniela M Ferreira; Debby Bogaert Journal: Nat Commun Date: 2019-07-05 Impact factor: 14.919
Authors: Simon P Jochems; Karin de Ruiter; Carla Solórzano; Astrid Voskamp; Elena Mitsi; Elissavet Nikolaou; Beatriz F Carniel; Sherin Pojar; Esther L German; Jesús Reiné; Alessandra Soares-Schanoski; Helen Hill; Rachel Robinson; Angela D Hyder-Wright; Caroline M Weight; Pascal F Durrenberger; Robert S Heyderman; Stephen B Gordon; Hermelijn H Smits; Britta C Urban; Jamie Rylance; Andrea M Collins; Mark D Wilkie; Lepa Lazarova; Samuel C Leong; Maria Yazdanbakhsh; Daniela M Ferreira Journal: J Clin Invest Date: 2019-07-30 Impact factor: 19.456
Authors: E Mitsi; A M Roche; J Reiné; T Zangari; J T Owugha; S H Pennington; J F Gritzfeld; A D Wright; A M Collins; S van Selm; M I de Jonge; S B Gordon; J N Weiser; D M Ferreira Journal: Mucosal Immunol Date: 2016-08-31 Impact factor: 7.313
Authors: Hans de Graaf; Muktar Ibrahim; Alison R Hill; Diane Gbesemete; Andrew T Vaughan; Andrew Gorringe; Andrew Preston; Annemarie M Buisman; Saul N Faust; Kent E Kester; Guy A M Berbers; Dimitri A Diavatopoulos; Robert C Read Journal: Clin Infect Dis Date: 2020-07-11 Impact factor: 9.079
Authors: Ben Morton; Sarah Burr; Kondwani Jambo; Jamie Rylance; Marc Y R Henrion; Ndaziona Peter Banda; Edna Nsomba; Blessings Kapumba; Lucinda Manda-Taylor; Clemens Masesa; Daniela Ferrreira; Stephen B Gordon Journal: Wellcome Open Res Date: 2020-04-14